Free Shipping on purchases over €100

Eucerin Anti-Pigment Day Cream SPF 30, 50 ml

Eucerin Antipigment Day Cream SPF 30, 50 ml is a moisturising day cream with SPF 30+ and protection against UVA and visible blue light. With the patented ingredient Thiamidol®, it reduces all types of dark spots and prevents their reappearance within 2 weeks. 50 ml pack.

SKU: 189213
-12%
35.20
€40.05
€70.40
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me
To treat blemishes effectively, it is necessary to use active ingredients that treat the blemish at different levels and in the different steps of the cosmetic routine. Do not forget sun protection to prevent new spots from appearing or getting worse.

0 products in total

INFO AND TECHNICAL SPECIFICATIONS

Exposure to sunlight, hormonal changes and ageing can lead to increased melanin production and cause hyperpigmentation. Hyperpigmentation appears in the form of dark areas or age spots (also known as sun spots) that give the skin an uneven appearance.

Eucerin® Anti-Pigment Day SPF 30 contains Thiamidol®, an effective, patented ingredient that targets the source of hyperpigmentation and reduces melanin production from day 1, with visible results in 2 weeks with regular use. It has been clinically and dermatologically proven to reduce all types of hyperpigmentation spots and prevent their reappearance.

Thanks to SPF 30 and protection against UVA and visible blue light, it helps prevent future sun-induced hyperpigmentation spots.

-Rapidly absorbed
Non-greasy
-Light texture

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.